BioSpace News Archive

HPPI’s patent portfolio expands with claims covering treatment of both hematologic and non-hematologic cancers with itraconazole, the active ingredient in HPPI’s current and anticipated future product candidates

Ansun is a leading biotechnology company focused on the development of novel broad spectrum anti-viral biologic therapeutics to combat severe viral respiratory tract infections.

Zynex, Inc. (OTCQB: ZYXI), today announced a program to buy back an additional $2 million of the Company’s common stock

Coincides with global Boeing well-being initiative Includes $500,000 for veteran recovery and rehabilitation services in Australia, UK and U.S.

TissueTech Inc., the pioneer in the development and clinical application of regenerative amniotic tissue-based products, announced that it has been awarded patent 9,808,491 by the U.S. Patent Trademark Office.

Beam Therapeutics announced today that it is launching to develop precision genetic medicines

BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.

Compact system enables radiologists and orthopedic specialists to visualize three-dimensional bone detail of the lower extremities while the patient is standing

Alkahest Inc. is a clinical-stage biotechnology company focused on developing innovative therapies to treat age-related diseases

Indivior PLC today announced that its U.S. subsidiary, Indivior Inc., together with Aquestive Therapeutics Inc., entered into a settlement agreement with Par Pharmaceutical, Inc., Par Pharmaceutical Companies Inc., Endo International PLC and IntelGenx Technologies Corp., resolving patent litigation related to SUBOXONE® Sublingual Film.